These results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the thought of targeting ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases.In response to this concern, the new exam